Geographic and temporal variations in cancer of the corpus uteri: Incidence and mortality in pre- and postmenopausal women in Europe

Abstract

Corpus uteri cancer is the fourth most common neoplasm in women in Europe and the tenth most common cause of cancer death. We examined geographic and temporal variations in corpus uteri cancer incidence and mortality rates in the age groups 25-49 and 50-74 in 22 European countries. The disease is considerably less common in premenopausal women, with incidence and mortality rates decreasing throughout Europe and mortality declines more marked in western and southern European countries. Incidence rates among postmenopausal women are highest in the Czech Republic, Slovakia, Sweden and Slovenia and lowest in France and the United Kingdom. Increasing incidence trends in this age group are observed in the Nordic countries (except Denmark) and in the United Kingdom. Some increases are also seen in eastern (Slovakia) and southern Europe (Spain and Slovenia), while relatively stable or modestly decreasing trends are observed in Italy and most western European countries. Postmenopausal mortality rates are systematically higher in eastern Europe, with death rates in the Ukraine, Latvia, Czech Republic, Russia and Belarus 2-3 times those seen in western Europe. Declining mortality trends are seen in most populations, though in certain Eastern European countries, the declines began rather recently, during the 1980s. In Belarus and Russia, recent postmenopausal death rates are stable or increasing. The rates are adjusted for misclassification of uterine cancer deaths but remain unadjusted for hysterectomy, and where there is an apparent levelling off of incidence or mortality rates recently, rising prevalence of hysterectomy cannot be discounted as an explanation. However, the trends by age group can be viewed in light of several established risk factors for endometrial cancer that are highly prevalent and most likely changing with time. These are discussed, as are the prospects for preventing the disease. ' 2005 Wiley-Liss, Inc.

Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial Cancer

“…Endometrial cancer is the most common gynecological malignancy in the western world and the incidence is rising in several countries (1). 15% to 20% of patients with presumed localized disease at primary treatment recur (2,3).…”

The effect of performing corrections on reported uterine cancer mortality data in the city of São Paulo

“…Several studies have reported relevant proportions of unspecified uterine cancer deaths or addressed the need of correcting estimates for cervical and corpus uteri cancer (6)(7)(8)(9)(10)(11)(12)(13)(23)(24)(25)(26)(27)(28)(29)39,40). The current assessment of different strategies to perform this correction indicated important modifications of the epidemiologic profile of cervix and corpus uteri cancer.…”

“…The partial correction represents a conservative option which considers that at least some of the deaths formerly classified as uterus NOS should remain unspecified as to the affected tissue. Although a further estimating process is subject to a higher risk of error, the full correction has been applied to several recent studies on uterine cancer mortality (10,23,40). In spite of the longstanding call for increased accuracy of the report of deaths by uterine cancer (7), the proportion of unspecified mortality remains high in the Brazilian context.…”

Therapeutic role of systematic lymphadenectomy in early-stage endometrial cancer: A systematic review

“…Endometrial cancer is one of the most prevalent malignant tumors of the female genital tract, accounting for 6% of all cases of cancer in women (1). According to the American Cancer Society, the annual incidence of endometrial cancer is increasing, with ~40,880 new cases diagnosed in the USA in 2005 (2) and ~49,560 new cases in 2013 (3).…”